InflaRx NV (IFRX)

IFRX.........................https://stockcharts.com/sc3/ui/?s=IFRX&p=W&b=5&g=0&id=p86431144783

IFRX......................................https://stockcharts.com/sc3/ui/?s=IFRX&p=W&b=5&g=0&id=p86431144783

IFRX...........................................https://stockcharts.com/sc3/ui/?s=IFRX&p=W&b=5&g=0&id=p86431144783

IFRX InflaRx Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU)
https://investorshub.advfn.com/stock-market/NASDAQ/inflarx-nv-IFRX/stock-news/97194845/inflarx-reports-positive-phase-2a-data-for-inf904

IFRX news .. InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria https://finance.yahoo.com/news/inflarx-announce-topline-data-phase-210500490.html

IFRX...........................................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

11 yrs. I-hub absence, how's C3P0?...kewl IFRx DD, lol. 😉😂🤣

IFRX, under $2

IFRX...............................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

InflaRx is entering a critical phase with several upcoming catalysts:

Phase 3 interim results for vilobelimab in Pyoderma Gangrenosum (PG) are expected shortly. The program already has both Fast Track and Orphan Drug Designation from the FDA, which could enable accelerated approval if the data are strong.

Phase 2a results for INF904 in Hidradenitis Suppurativa (HS) and Chronic Spontaneous Urticaria (CSU) are anticipated this summer. Both indications target large unmet medical needs and multi-billion-dollar markets.

Preclinical data for INF904 showed superior efficacy compared to Avacopan, which was acquired by Amgen for $3.7B.

InflaRx maintains a cash position of approximately $70M, suggesting the company is fully funded through these major milestones.

Guggenheim Securities has issued a $10 price target for IFRX, representing significant upside potential from current levels.

With multiple important readouts expected this year, IFRX could attract substantial attention if results are positive.

DYOR (Do Your Own Research)

IFRX, under $2

IFRX, under $2

ifrx...................................https://stockcharts.com/h-sc/ui?s=ifrx&p=W&b=5&g=0&id=p86431144783

IFRX.................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

IFRX..............................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

IFRX.........................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

IFRX.............................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

IFRX....................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

Is it just the strong financial reports or is there some other news you know of?
Thanks!

IFRX READY TO RUMBLE IN THE JUNGLE 2.9 TOP OF WEEKLY PLAY

IFRX.............................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

anyone know why its launching?

IFRX TAKING OFF

IFRX.......................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

IFRX 10Q due AUGUST5

IFRX under $2

IFRX under $2

IFRX..................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

What is up with IFRX? Seems to be teetering. Numbers look good, except for Forward EPS.

IFRX...............................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

IFRX under $2

IFRX under $2

IFRX................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783

IFRX under $2

IFRX new 52 week low

https://finviz.com/quote.ashx?t=IFRX&ty=c&ta=1&p=d

does have a REGISTERED SHELF OFFERING

https://dilutiontracker.com/app/search/IFRX?a=dbb88c

Apr-05-23 Upgrade Guggenheim Neutral ? Buy $8

True waiting on that skin cancer p2 data release or EUA sales update.

going the wronge way

yup $10+ coming

I added more and its a decent position. I think we have a shot at 10 to 15 short term. Friday looked promising. Hopefully we get a second wave to start in 2 weeks.

you still in ????
im still holding 4s

Closing of offering, here comes first stop $6.25

IFRX should go slowly 5$ +

IFRX 4.2 now slowly on the move

in here at 4.10

Still in downtrend and they will keep diluting

I bought more 4.04

Couple of pennies are cloce enough

Learn your charts lol $3.93 is the gap fill

Gap filled boys and girls...
Big boy buying today !!!